Join as an individual or organization
The World Health Organisation (WHO) estimates that one in five African adolescents use tobacco and predict a doubling of deaths related to tobacco use in low- and middle-income countries between 2002 and 2030.
Here, you can find out more...
In the context of an ongoing expansion of the global cocaine market, this report summarizes the current state of knowledge on what cocaine consumer products are and how they are produced and consumed in different world regions. The report...
The cocaine market presents a clear threat at the global level. Well-defined locations of production in South America and large consumer markets in the Americas and Europe lead to trafficking routes from a circumscribed origin to specific...
The United Nations Office on Drugs and Crime (UNODC) and specifically the Prevention Treatment and Rehabilitation Section (PTRS) are working on addressing substance use and substance use disorders in humanitarian settings.
In this context...
The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use.
The guide is composed of four sets of miniguides that look...
This new annual themed issue of Advances in Dual Diagnosis will focus on issues surrounding dual diagnosis in older adults in order to improve assessment intervention, treatment and care of older adults with dual diagnosis from both public...
Problematic substance use can be a significant cause of stress for family members of the person using substances. This review, published in the journal Drug: Education, Prevention and Policy, examines current research in order to explore...
The Alcoholics Anonymous (AA) movement created the term "in recovery" to express the continuing requirement for vigilance in order to sustain sobriety (which includes abstinence from alcohol intake) and avoid a return to dangerous drinking...
The SPR Board of Directors has allocated $3,000 in funds to support early-career prevention researchers to attend the EUSPR. The purpose of the travel funds is to enable ECPNers to attend EUSPR and network on behalf of SPR, especially with...
Stigma is a major barrier to the well-being and recovery of people with lived and living experience of substance use disorders.
This animated video about two friends, Alex and Sam, explores the devastating impact of substance use stigma...
This report presents the current status of alcohol consumption, alcohol-attributable harms and the implementation of alcohol control policies in the WHO European Region, using available data from 2010, 2016 and 2019.
A detailed overview is...
The EU Strategy 2021-2025 puts further emphasis on QS and evidence-based interventions.
Yet, the extent and ways in which QS are implemented in daily practices of drug prevention, treatment and harm reduction in the EU varies substantially...
This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System.
The aim of this report is to strengthen situational awareness of synthetic...
This online course provides an overview of how community health workers (CHWs) can support their communities by providing appropriate mental health and psychosocial support during the COVID-19 pandemic.
In this course you will learn how...
Social Determinants & Substance Use: A Perspective Beyond the Policy 'Silo' Pragmatics - This paper (synoptic version, peer reviewed and published in Journal of Global Drug Policy & Practice) is a review of and research into the social...
This qualitative study was commissioned by Alcohol Change UK in Wales to explore how and why alcohol and self-harm are related, and how alcohol, self-harm, and related services, are experienced and understood. Eleven...
According to the World Health Organisation, around half a million deaths each year are attributable to drug use. More than 70% of these deaths are related to opioids, with more than 30% of those deaths caused by overdose. Signs, symptoms...
